About
Cannabis-based Pharmaceutical Products
Sade Biotech developed ASAYA, a platform for optimization of clinical outcomes by managing medical cannabis treatment with big data analysis and algorithms based on experts’ best practices.
ASAYA integrates real-world practice and patients reported outcomes, with human and machine intelligence, to provide practical guidance for the use of medical cannabis. Facilitated by cutting edge technology – machine learning, IoT, mobile applications and predictive analytics – ASAYA promotes to better medical cannabis care. Ultimately, the whole medical cannabis ecosystem will benefit – HCPs, patients, growers & researchers.
Identity
| Name | Sade Group |
|---|---|
| Slug | sade-group |
| Type / kind | startup |
| Crunchbase ID | sade-group-aeac |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KKTo5QKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Pinhas Sapir Street 8, Ness Ziona, Israel |
Web & social
| Website | https://www.sade.group/ |
|---|---|
| https://www.linkedin.com/company/35452848 | |
| https://www.facebook.com/sade.biotech |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Platforms & InterfacesAPIArtificial IntelligenceMachine LearningCommunicationsBluetooth
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business models
B2B
Tags
pain-reliefbreedingagtechskin-careinflammatory-diseasescannabiscosmeticsfoodtechdermatologydrug-deliverymedical-cannabisacnepharmaceuticals
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}